THE BINDING-PROPERTIES OF THE MUSCARINIC RECEPTORS OF THE CYNOMOLGUS MONKEY CILIARY BODY AND THE RESPONSE TO THE INDUCTION OF AGONIST SUBSENSITIVITY

被引:31
作者
BARANY, E
BERRIE, CP
BIRDSALL, NJM
BURGEN, ASV
HULME, EC
机构
[1] UNIV UPPSALA, DEPT MED PHARMACOL, S-75105 UPPSALA, SWEDEN
[2] NATL INST MED RES, DIV MOLEC PHARMACOL, LONDON NW7 1AA, ENGLAND
关键词
D O I
10.1111/j.1476-5381.1982.tb09353.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding properties of the muscarinic receptors in the ciliary muscle of cynomolgus monkeys were evaluated. The concentration of receptor binding sites is the highest yet reported. As found in many species and tissues, there are subclasses of agonist binding sites. Agonist binding [pirenzepine, carbachol and pilocapine] is not affected by the non-hydrolyzable (GTP) analog, GppNHp, suggesting that these receptors are not linked to adenylate cyclase. Ciliary muscles made subsensitive by treatment with muscarinic agonists have a decreased receptor concentration but no other changes in the binding properties of the receptors could be detected. [The radiologand used [3H]-N-methylscopolamine, a potent muscarinic antagonist.].
引用
收藏
页码:731 / 739
页数:9
相关论文
共 29 条
[11]  
EHLERT FJ, 1980, MOL PHARMACOL, V17, P24
[12]  
GALPER JB, 1980, J BIOL CHEM, V255, P9571
[13]   PIRENZEPINE DISTINGUISHES BETWEEN DIFFERENT SUBCLASSES OF MUSCARINIC RECEPTORS [J].
HAMMER, R ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV ;
HULME, EC .
NATURE, 1980, 283 (5742) :90-92
[14]  
HULME EC, 1978, MOL PHARMACOL, V14, P737
[15]   2 POPULATIONS OF BINDING-SITES FOR MUSCARINIC ANTAGONISTS IN THE RAT-HEART [J].
HULME, EC ;
BERRIE, CP ;
BIRDSALL, NJM ;
BURGEN, ASV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 73 (2-3) :137-142
[16]  
HULME EC, 1980, DRUG RECEPTORS THEIR, P23
[17]  
ISHIKAWA T, 1962, INVEST OPHTH VISUAL, V1, P587
[18]  
KAUFMAN PL, 1975, INVEST OPHTH VISUAL, V14, P302
[19]   A COMPARATIVE STUDY OF AUTONOMIC INNERVATION OF EYE IN MONKEY CAT RABBIT [J].
LATIES, AM ;
JACOBOWI.D .
ANATOMICAL RECORD, 1966, 156 (04) :383-&
[20]  
MARKS MJ, 1981, J PHARMACOL EXP THER, V218, P337